The regulator lifted a clinical hold on Verve Therapeutics’ CRISPR-based therapy clearing its Investigational New Drug application and plans to evaluate VERVE-…
The company’s experimental lgG4 antibody met the primary endpoint in a late-stage study of the rare skin disease. AnaptysBio will submit an application to the …
Thursday’s approval comes after the FDA pushed back the target action dates for Amicus’ Biologics License Application in May, allowing the regulator more time …
The FDA on Monday approved the Canadian biopharma’s liquid antibiotic metronidazole, an alternative for patients who are unable to use pills or injections.
The biopharma’s acute myeloid leukemia hopeful is on partial clinical hold, affecting two Phase III AML studies, Gilead announced Monday. The CD47 candidate al…
The company’s first-in-class small molecule imipridone, ONC201, showed strong efficacy results in two early-stage clinical trials of 71 pediatric patients wit…
HIV and the chronic inflammation it causes, paired with a diminished immune system, can result in unwanted cardiovascular complications in patients. Specific…
Chronically high blood sugar levels, high blood pressure, abnormal lipid levels, and inflammation are hallmark causes of atherosclerosis. Type 2 diabetics ar…
Endocarditis infects and inflames the heart’s inner lining and compromises heart valves, often requiring repair or replacement. In the past, rheumatic fever …